A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 114
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ISSHL
Long Form : idiopathic sudden sensorineural hearing loss
No. Year Title Co-occurring Abbreviation
2020 A Preliminary Report on the Investigation of Prestin as a Biomarker for Idiopathic Sudden Sensorineural Hearing Loss. ---
2020 A Prognostic Marker in Idiopathic Sudden Sensorineural Hearing Loss: Serum Calprotectin. ---
2020 Clinical efficacy of hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss. dB
2020 Comparing the Efficiencies of Hyperbaric Oxygen Therapy and Intratympanic Steroid Treatment for Sudden Hearing Loss. HBOT, HG, ITS, SST
2020 Impact of hyperlipidemia as a coexisting factor on the prognosis of idiopathic sudden sensorineural hearing loss: A propensity score matching analysis. CG, CMH, LLTG
2020 Metabolic syndrome and idiopathic sudden sensori-neural hearing loss. BMI, IDF, MetS, WHR
2020 Ocular and cervical vestibular-evoked myogenic potentials in idiopathic sudden sensorineural hearing loss (ISSHL) without vertigo: VEMPs in ISSHL. ---
2020 The efficacy of intratympanic steroid injection for the treatment of idiopathic sudden sensorineural hearing loss. IT, PTA
2019 Early Magnetic Resonance Imaging for Patients With Idiopathic Sudden Sensorineural Hearing Loss in an Emergency Setting. MR
10  2019 Efficacy of intratympanic corticosteroid as a salvage treatment in idiopathic sudden sensorineural hearing loss. ---
11  2019 Investigation of Stress Levels before the Onset of Idiopathic Sudden Sensorineural Hearing Loss. HbA1c
12  2019 Nationwide Survey of Intratympanic Steroids for the Management of Sudden Sensorineural Hearing Loss. IT
13  2019 The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review. AAT
14  2018 Idiopathic sudden sensorineural hearing loss and meniere syndrome: The role of cerebral venous drainage. MD, PTA
15  2018 Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss. IT, PTA, SDS
16  2018 Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: A systematic review and meta-analysis. CI, NLR, SMD
17  2018 The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review. HBO, SS
18  2018 [Sleep quality analysis in patients with unilateral idiopathic sudden sensorineural hearing loss]. ---
19  2017 A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. ITS, MD, OR, SST
20  2017 Adjunctive hyperbaric oxygen treatment for idiopathic sudden sensorineural hearing loss. PTA
21  2017 Diagnostics and therapy of sudden hearing loss. ILS
22  2017 ECHM Consensus Conference and levels of evidence - Reply. EBM, ECHM, HBOT, RCT
23  2017 ECHM Consensus Conference and levels of evidence. DCS, HBOT, RCTs
24  2017 Framingham Risk Score as a Prognostic Predictor of Sudden Sensorineural Hearing Loss: A Preliminary Study. FRS, PTA
25  2017 Studying the Association between Sudden Hearing Loss and DNA N-Methyltransferase 1 (DNMT1) Genetic Polymorphism. DNMT1, SNP
26  2017 Use of Vasodilators In Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review. ---
27  2017 [Diagnostics and Therapy of Idiopathic Sudden Sensorineural Hearing Loss]. ILS
28  2016 Complete recovery following hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss--a report of two cases. ---
29  2016 Endothelial Dysfunction in Idiopathic Sudden Sensorineural Hearing Loss: A Review. SSHL
30  2016 Ethics of Placebo Control in Trials for Idiopathic Sudden Sensorineural Hearing Loss. ---
31  2016 Evaluation of heart rate variability and night-time blood pressure measurements in patients with idiopathic sudden sensorineural hearing loss. DBP, HRV, SBP
32  2016 Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss: a retrospective analysis of outcomes. ---
33  2016 [Multicenter trial for sudden hearing loss therapy - planning and concept]. RCTs
34  2015 Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study. DM, HTN, i.t
35  2015 High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss. apoB, LDL, TC
36  2015 Oral steroid treatment for idiopathic sudden sensorineural hearing loss. PTA
37  2015 Uni- and multivariate models for investigating potential prognostic factors in idiopathic sudden sensorineural hearing loss. ---
38  2015 Variables with prognostic value in the onset of idiopathic sudden sensorineural hearing loss. ---
39  2015 [Clinical analysis of idiopathic sudden sensorineural hearing loss with vertigo]. BPPV
40  2015 [Intratympanic Steroid Treatment for Severe Idiopathic Sudden Sensorineural Hearing Loss]. HBO, ITS, IVS, PTA
41  2014 Altered autonomic regulation as a cardiovascular risk marker for patients with sudden sensorineural hearing loss. BP, CON, HR
42  2014 Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss. ---
43  2014 Glucocorticoid influence on prognosis of idiopathic sudden sensorineural hearing loss. ---
44  2014 Hyperbaric oxygen therapy (HBO2) as an adjunct in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL)--a case report on two patients. atm abs
45  2014 Increased neutrophil-lymphocyte ratio in patients with idiopathic sudden sensorineural hearing loss. NLR
46  2014 Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss. ---
47  2014 Labyrinthine artery detection in patients with idiopathic sudden sensorineural hearing loss by 7-T MRI. 3D TOF SPGR, MRI
48  2014 Management of sudden hearing loss with hyperbaric oxygen therapy. ---
49  2014 Meteorological conditions related to the onset of idiopathic sudden sensorineural hearing loss. ---
50  2014 Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss. GP
51  2014 Prognostic value of serum anti-heat-shock protein 70 and paraoxonase levels in idiopathic sudden sensorineural hearing loss. anti-HSP 70, PON
52  2014 The clinical value of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging in patients with idiopathic sudden sensorineural hearing loss: a meta-analysis. HS
53  2014 [Treatment outcome of patients with idiopathic sudden sensorineural hearing loss and concomitant benign paroxysmal positional vertigo]. BPPV
54  2013 Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramon y Cajal experience and review of the literature. ---
55  2013 Quality of life reported by patients with idiopathic sudden sensorineural hearing loss. BP, BSHL, MCS, QOL
56  2013 Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. HBO, IT
57  2013 Self-reported symptoms in patients with idiopathic sudden sensorineural hearing loss. USHL
58  2013 [Multi-center study on the treatment of sudden total deafness]. ---
59  2013 [Tympanotomy and sealing of the round window membrane in sudden sensorineural hearing loss: a retrospective analysis]. ---
60  2012 Antivirals for idiopathic sudden sensorineural hearing loss. CENTRAL, one patient in each
61  2012 Benign paroxysmal positional vertigo accompanied by sudden sensorineural hearing loss: a comparative study with idiopathic benign paroxysmal positional vertigo. BPPV, CRP, i-BPPV, s-BPPV
62  2012 Comparison of hearing recovery criteria in sudden sensorineural hearing loss. ---
63  2012 Endothelial function and cardiovascular risk in patients with idiopathic sudden sensorineural hearing loss. CIMT, FMD
64  2012 Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. ---
65  2012 Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy. IST, PTA
66  2012 Novel in vivo imaging analysis of an inner ear drug delivery system in mice: comparison of inner ear drug concentrations over time after transtympanic and systemic injections. TT
67  2011 Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study. ---
68  2011 Early transtympanic steroid injection in patients with 'poor prognosis' idiopathic sensorineural sudden hearing loss. ---
69  2011 Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation. ITD
70  2010 Assessment of variation throughout the year in the incidence of idiopathic sudden sensorineural hearing loss. ---
71  2010 Edaravone, a free radical scavenger, in the treatment of idiopathic sudden sensorineural hearing loss with profound hearing loss. HBO
72  2010 Local hypothermia in the treatment of idiopathic sudden sensorineural hearing loss. ---
73  2010 Predictive model for improvement of idiopathic sudden sensorineural hearing loss. CIs
74  2009 Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. IT
75  2009 Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Dex-P
76  2009 Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. CENTRAL, RCTs
77  2009 [Does acute sensorineural deafness befall to urgent conditions?]. ---
78  2008 Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. ---
79  2008 Saccular damage in patients with idiopathic sudden sensorineural hearing loss without vertigo. VEMP
80  2008 Sudden deafness: is it viral? ---
81  2008 Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. ---
82  2007 A recovery from enhancement of activation in auditory cortex of patients with idiopathic sudden sensorineural hearing loss. AEFs, AP, RPs
83  2007 Clinical haemorheology and microcirculation. DI, eNOS, NO, RVO, SSc
84  2007 Comparison of pure-tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. ---
85  2007 Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. CENTRAL, DORCTHIM, HBOT, NNT, NRR, PTA, RR
86  2007 Intratympanic steroids for idiopathic sudden sensorineural hearing loss. IT
87  2007 The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial. ---
88  2006 Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss. ABR, DPOAE, VEMP
89  2006 Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss. dB, HBO, MT, PTA
90  2006 Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome. ---
91  2006 Steroids for idiopathic sudden sensorineural hearing loss. CENTRAL
92  2005 eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms. NO, OR
93  2005 Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. CI, HBOT, NNT, PTA, RR
94  2005 Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a systematic review of randomized controlled trials. CI, HBOT, RR
95  2005 Idiopathic sudden sensorineural hearing loss in children. ---
96  2005 Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. ---
97  2005 Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss. DI, PLV, SonACT, WBV
98  2005 [Idiopathic sudden sensorineural hearing loss: a review]. ---
99  2004 Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? HBO
100  2003 Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. ---